Hence then, the article about diaprost licenses its novel theranostic antibody hu5a10 to radiopharm theranostics for development in the treatment and diagnosis of prostate cancer was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Diaprost Licenses its novel Theranostic Antibody, hu5A10, to Radiopharm Theranostics for Development in the Treatment and Diagnosis of Prostate Cancer. )
Last updated :
Also on site :
- Tokyo's Yamanote Line suspended due to power outage
- 2000s Heavy Metal Band Shares Exciting Music Festival News
- Tokyo's Yamanote loop line trains out of service due to power outage